Amir Mahmoud, MBBCh

Amir Mahmoud, MBBCh

ASH HFFTP Fellow

Hometown: Cairo, Egypt
Medical School: Ain Shams University School of Medicine
Residency: Rochester General Hospital
Research/Academic Interests: Classical Hematology, Thrombosis & Hemostasis, Clinical and outcomes research
Bio: I have lived in multiple cities growing up and love travelling/exploring new cultures. My hobbies include anything involving food or coffee, soccer, kayaking and chess. I enjoy playing the acoustic guitar in my free time and binge-watching TV shows with my wife. Looking forward to exploring the phenomenal food and music scene in St. Louis!

Selected Publications/Abstracts

  • Mahmoud, A.A., Abdelhay, A., Mostafa, M., Yassin, H., Jadhav, N. and Kouides, P. (2023), Treatment delay and outcomes in elderly thrombotic thrombocytopenic purpura patients: A nationwide analysis. Am J Hematol, 98: E161-E164. https://doi.org/10.1002/ajh.26926
  • Mostafa, M., Mahmoud, A.A., Egiza, H.-A., Niu, C., Elbahnasawy, M., Yusuf, Y. and Kouides, P. (2023), Severe cutaneous necrosis in antiphospholipid syndrome. Am J Hematol, 98: E328-E333. https://doi.org/10.1002/ajh.27067
  • Singal, M., Mahmoud, A.A., & Phatak, P. D. (2024). Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homozygotes. Expert Review of Hematology, 17(4–5), 145–152. https://doi.org/10.1080/17474086.2024.2337950
  • Low, S.K., Anjum, Z., Mahmoud, A.A., Joshi, U., Kouides, P. Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis. Thromb Res. 2022 Nov;219:14-21. doi: 10.1016/j.thromres.2022.08.029. Epub 2022 Sep 6. PMID: 36088710.
  • Neupane, N., Thapa, S., Mahmoud, A.A., Bhattarai, A., KC, A., Shikhrakar, S., et al. Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpura. eJHaem. 2024; 5: 178–190. https://doi.org/10.1002/jha2.833
  • Mahmoud, A.A., Abdelhay, A., Khamis, A. et al. Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis. Ann Hematol 102, 1705–1711 (2023). https://doi.org/10.1007/s00277-023-05223-4
  • Neupane, N., Low, S.K., Kharel, H., Bhattarai, S., Thapa, S., Mahmoud, A.A., Pokhrel, N.B., Ammad Ud Din, M. and Kouides, P. (2024), Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia. Am J Hematol, 99: E26-E28. https://doi.org/10.1002/ajh.27148